Differentiating Septic Arthritis from Lyme Disease Arthritis in Children’s Knees
By LabMedica International staff writers Posted on 24 May 2016 |

Image: Adult deer tick Ixodes scapularis. Lyme disease is caused by Borrelia bacteria and transmitted to humans upon the bite of infected ticks of the genus Ixodes (Photo courtesy of Scott Bauer, Agricultural Research Service of United States Department of Agriculture).
The two conditions often include similar symptoms and both can show elevated measurements in laboratory tests for inflammation and for white blood cell (WBC) counts – however each condition requires different immediate treatment. A new study identifies symptoms that are predictive of septic arthritis when the condition presents itself in a child’s knee – an important distinction in areas where Lyme disease is endemic.
Septic arthritis is considered a medical emergency and includes the need for surgical irrigation (flushing) and drainage to prevent rapid and irreversible destruction of the cartilage surrounding the knee. Lyme disease is treated with antibiotics. In addition to knee swelling and pain, both conditions may cause a fever, swelling of other joints, irritability, and an inability to bear weight on the affected extremity.
Researchers at Children’s Hospital of Philadelphia (CHOP; Philadelphia, PA, USA) performed a retrospective review study of records of 189 patients under age 18 who presented with excess fluid in the knee between 2005 and 2013. Patients with either septic arthritis (positive joint-fluid culture or synovial WBC count of >60,000 WBC/mm3 with negative Lyme titer) or Lyme disease (positive Lyme immunoglobulin G on Western blot analysis) were included. Of the 189 patients: 23 had culture-positive septic arthritis; 26 had culture-negative septic arthritis; and 140 had Lyme disease.
Upon statistical analysis, 4 characteristics were identified as independent predictive factors for pediatric septic arthritis: presence of knee pain with short range of motion, C-reactive protein of >4.0 mg/liter (CRP test used to measure inflammation), patient-reported history of fever, and age younger than 2 years. The more factors that are present, the higher the risk of having septic arthritis.
“The probability of septic arthritis with any 1 factor present was 18% compared to 100% with all 4 factors present," said study author Wudbhav N. Sankar, MD, orthopaedic surgeon at CHOP, "Our study offers a useful prediction algorithm to help distinguish septic arthritis from a knee effusion caused by Lyme disease in children.”
The study, by Baldwin KD et al, was published May 4, 2016, in the Journal of Bone and Joint Surgery.
Related Links:
Children’s Hospital of Philadelphia
Septic arthritis is considered a medical emergency and includes the need for surgical irrigation (flushing) and drainage to prevent rapid and irreversible destruction of the cartilage surrounding the knee. Lyme disease is treated with antibiotics. In addition to knee swelling and pain, both conditions may cause a fever, swelling of other joints, irritability, and an inability to bear weight on the affected extremity.
Researchers at Children’s Hospital of Philadelphia (CHOP; Philadelphia, PA, USA) performed a retrospective review study of records of 189 patients under age 18 who presented with excess fluid in the knee between 2005 and 2013. Patients with either septic arthritis (positive joint-fluid culture or synovial WBC count of >60,000 WBC/mm3 with negative Lyme titer) or Lyme disease (positive Lyme immunoglobulin G on Western blot analysis) were included. Of the 189 patients: 23 had culture-positive septic arthritis; 26 had culture-negative septic arthritis; and 140 had Lyme disease.
Upon statistical analysis, 4 characteristics were identified as independent predictive factors for pediatric septic arthritis: presence of knee pain with short range of motion, C-reactive protein of >4.0 mg/liter (CRP test used to measure inflammation), patient-reported history of fever, and age younger than 2 years. The more factors that are present, the higher the risk of having septic arthritis.
“The probability of septic arthritis with any 1 factor present was 18% compared to 100% with all 4 factors present," said study author Wudbhav N. Sankar, MD, orthopaedic surgeon at CHOP, "Our study offers a useful prediction algorithm to help distinguish septic arthritis from a knee effusion caused by Lyme disease in children.”
The study, by Baldwin KD et al, was published May 4, 2016, in the Journal of Bone and Joint Surgery.
Related Links:
Children’s Hospital of Philadelphia
Latest Microbiology News
- New Test Diagnoses Bacterial Meningitis Quickly and Accurately
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
Channels
Clinical Chemistry
view channel
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Genetic-Based Tool Predicts Survival Outcomes of Pancreatic Cancer Patients
A tumor marker is a substance found in the body that may signal the presence of cancer. These substances, which can include proteins, genes, molecules, or other biological compounds, are either produced... Read more
Urine Test Diagnoses Early-Stage Prostate Cancer
Prostate cancer is one of the leading causes of death among men worldwide. A major challenge in diagnosing the disease is the absence of reliable biomarkers that can detect early-stage tumors.... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read moreTechnology
view channel
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more